Il y a eu 50 transactions d'initiés récentes enregistrées pour Solid Biosciences Inc. (SLDB), dont 3 achats et 47 ventes. Le total des achats d'initiés s'élève à $8.91K et le total des ventes d'initiés à $2.53M.
Les initiés notables ayant une activité récente comprennent Smith Ian F, Perceptive Advisors Llc, Howton David T. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — SLDB
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-04-02 |
Smith Ian F |
Director |
Exercice d'Options (Vente) |
3,441 |
- |
- |
10,320 |
| 2026-03-09 |
Perceptive Advisors Llc |
10 Percent Owner |
Attribution de RSU |
8,912,655 |
$0.00 |
$8.91K |
8,912,655 |
| 2026-02-18 |
Howton David T |
Chief Operating Officer |
Vente Informative |
7,469 |
$5.82 |
$43.49K |
105,077 |
| 2026-02-18 |
Cumbo Alexander |
President and CEO |
Vente Informative |
16,644 |
$5.82 |
$96.92K |
235,405 |
| 2026-02-18 |
Ganot Ilan |
Director |
Vente Informative |
2,658 |
$5.82 |
$15.48K |
27,474 |
| 2026-02-18 |
Tan Kevin |
CFO & Treasurer |
Vente Informative |
5,404 |
$5.82 |
$31.47K |
99,422 |
| 2026-02-18 |
Hanrahan Jessie |
Chief Regulatory Officer |
Vente Informative |
4,134 |
$5.82 |
$24.07K |
74,318 |
| 2026-02-18 |
Herzich Paul |
Chief Technology Officer |
Vente Informative |
3,616 |
$5.82 |
$21.06K |
72,638 |
| 2026-02-18 |
Brooks Gabriel |
Chief Medical Officer |
Vente Informative |
- |
$5.82 |
- |
89,466 |
| 2026-02-13 |
Howton David T |
Chief Operating Officer |
Exercice d'Options (Vente) |
14,687 |
- |
- |
29,376 |
| 2026-02-13 |
Cumbo Alexander |
President and CEO |
Exercice d'Options (Vente) |
30,031 |
- |
- |
60,063 |
| 2026-02-13 |
Ganot Ilan |
Director |
Exercice d'Options (Vente) |
4,861 |
- |
- |
9,722 |
| 2026-02-13 |
Tan Kevin |
CFO & Treasurer |
Exercice d'Options (Vente) |
10,625 |
- |
- |
21,250 |
| 2026-02-13 |
Hanrahan Jessie |
Chief Regulatory Officer |
Exercice d'Options (Vente) |
8,125 |
- |
- |
16,250 |
| 2026-02-13 |
Herzich Paul |
Chief Technology Officer |
Exercice d'Options (Vente) |
7,187 |
- |
- |
14,376 |
| 2026-02-13 |
Brooks Gabriel |
Chief Medical Officer |
Exercice d'Options (Vente) |
10,937 |
- |
- |
21,876 |
| 2026-02-04 |
Howton David T |
Chief Operating Officer |
Vente Informative |
18,894 |
$6.44 |
$121.71K |
97,859 |
| 2026-02-04 |
Cumbo Alexander |
President and CEO |
Vente Informative |
48,913 |
$6.44 |
$315.09K |
222,018 |
| 2026-02-04 |
Ganot Ilan |
Director |
Vente Informative |
7,205 |
$6.44 |
$46.41K |
25,271 |
| 2026-02-04 |
Tan Kevin |
CFO & Treasurer |
Vente Informative |
14,783 |
$6.44 |
$95.23K |
94,201 |
| 2026-02-04 |
Hanrahan Jessie |
Chief Regulatory Officer |
Vente Informative |
12,348 |
$6.44 |
$79.54K |
70,327 |
| 2026-02-04 |
Herzich Paul |
Chief Technology Officer |
Vente Informative |
10,905 |
$6.44 |
$70.25K |
69,067 |
| 2026-02-04 |
Brooks Gabriel |
Chief Medical Officer |
Vente Informative |
12,616 |
$6.44 |
$81.27K |
84,092 |
| 2026-02-02 |
Howton David T |
Chief Operating Officer |
Vente Informative |
37,771 |
$6.44 |
$243.13K |
116,753 |
| 2026-02-02 |
Cumbo Alexander |
President and CEO |
Vente Informative |
80,258 |
$6.44 |
$516.61K |
270,931 |
| 2026-02-02 |
Tan Kevin |
CFO & Treasurer |
Vente Informative |
26,837 |
$6.44 |
$172.75K |
108,984 |
| 2026-02-02 |
Hanrahan Jessie |
Chief Regulatory Officer |
Vente Informative |
26,535 |
$6.44 |
$170.8K |
82,675 |
| 2026-02-02 |
Herzich Paul |
Chief Technology Officer |
Vente Informative |
26,250 |
$6.44 |
$168.97K |
79,972 |
| 2026-02-02 |
Brooks Gabriel |
Chief Medical Officer |
Vente Informative |
28,335 |
$6.44 |
$182.39K |
96,708 |
| 2026-01-31 |
Howton David T |
Chief Operating Officer |
Exercice d'Options (Vente) |
42,275 |
- |
- |
126,825 |
| 2026-01-31 |
Cumbo Alexander |
President and CEO |
Exercice d'Options (Vente) |
100,400 |
- |
- |
301,200 |
| 2026-01-31 |
Ganot Ilan |
Director |
Exercice d'Options |
15,000 |
- |
- |
32,476 |
| 2026-01-31 |
Tan Kevin |
CFO & Treasurer |
Exercice d'Options (Vente) |
33,075 |
- |
- |
99,225 |
| 2026-01-31 |
Hanrahan Jessie |
Chief Regulatory Officer |
Exercice d'Options (Vente) |
27,625 |
- |
- |
82,875 |
| 2026-01-31 |
Herzich Paul |
Chief Technology Officer |
Exercice d'Options (Vente) |
24,675 |
- |
- |
74,025 |
| 2026-01-31 |
Brooks Gabriel |
Chief Medical Officer |
Exercice d'Options (Vente) |
28,225 |
- |
- |
84,675 |
| 2026-01-29 |
Howton David T |
Chief Operating Officer |
Exercice d'Options (Vente) |
79,341 |
- |
- |
- |
| 2026-01-29 |
Cumbo Alexander |
President and CEO |
Exercice d'Options (Vente) |
169,401 |
- |
- |
- |
| 2026-01-29 |
Ganot Ilan |
Director |
Attribution de RSU |
35,450 |
- |
- |
35,450 |
| 2026-01-29 |
Tan Kevin |
CFO & Treasurer |
Exercice d'Options (Vente) |
56,646 |
- |
- |
- |
| 2026-01-29 |
Hanrahan Jessie |
Chief Regulatory Officer |
Exercice d'Options (Vente) |
54,925 |
- |
- |
- |
| 2026-01-29 |
Herzich Paul |
Chief Technology Officer |
Exercice d'Options (Vente) |
54,925 |
- |
- |
- |
| 2026-01-29 |
Brooks Gabriel |
Chief Medical Officer |
Exercice d'Options (Vente) |
58,847 |
- |
- |
- |
| 2026-01-28 |
Ganot Ilan |
Director |
Vente Informative |
191 |
$6.59 |
$1.26K |
17,476 |
| 2026-01-27 |
Ganot Ilan |
Director |
Exercice d'Options (Vente) |
3,884 |
- |
- |
- |
| 2026-01-13 |
Tan Kevin |
CFO & Treasurer |
Vente Informative |
5,704 |
$5.27 |
$30.06K |
46,100 |
| 2026-01-09 |
Tan Kevin |
CFO & Treasurer |
Exercice d'Options (Vente) |
11,250 |
- |
- |
11,250 |
| 2026-01-06 |
Smith Ian F |
Director |
Exercice d'Options (Vente) |
4,573 |
- |
- |
- |
| 2026-01-05 |
Ganot Ilan |
Director |
Vente Informative |
1,053 |
$5.43 |
$5.72K |
17,278 |
| 2026-01-03 |
Ganot Ilan |
Director |
Exercice d'Options (Vente) |
2,994 |
- |
- |
2,994 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
